SEC23B is Very Rarely Studied in Cancer   Enters the nucleus and plays other roles

SEC23B is Very Rarely Studied in Cancer Enters the nucleus and plays other roles

User Photo
Cancer-News

2 years
121 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Charis Eng, MD, PhD, Genomic Medicine Institute - Cleveland Clinic, explains SEC23B is Very Rarely Studied in Cancer Enters the nucleus and plays other roles at AACR 2018.
Up Next Autoplay